Initially, your doctor may administer the injection frequently (e.g., daily or weekly), then transition to less frequent injections (e.g., monthly) for maintenance, especially when treating conditions like pernicious anemia
5-Amino-1MQ oral and subcutaneous route comparison Factor Administration Oral capsules Capsule taken by mouth Subcutaneous injection Reconstituted solution placed under the skin Factor Commonly discussed research amounts Oral capsules 50 to 150 mg per day in community reports Subcutaneous injection 2.5 to 5 mg per day in community reports Factor Frequency Oral capsules Once daily or split between morning and midday Subcutaneous injection Usually discussed as once daily, with some split examples Factor Absorption evidence Oral capsules 38.4% oral bioavailability in one rat study
How does the peptide BPC-157 work
Appearance is diagnostic in a way it is not for peptides: 5-amino-1MQ is typically a yellow to orange solid rather than a white lyophilised cake, so anyone judging the material by expecting a white powder will conclude something is wrong when it is not, and equally will miss a genuine colour change that indicates degradation
The peptide is unaffected